![A person stating at screens](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Person%20with%20Technology.jpg.webp?itok=BTrLT_Ei)
Featured Legislative & Regulatory Positions
See all Positions![A person stating at screens](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Person%20with%20Technology.jpg.webp?itok=BTrLT_Ei)
AMCP supports increased access to Prescription Digital Therapeutics (PDTs). PDTs are software-based therapies that deliver clinical benefits to patients, either alone or in combination with other forms of treatment. These therapeutics require a prescription and are subject to oversight by the Food and Drug Administration (FDA). To be approved by the FDA, PDTs must demonstrate both safety and efficacy.
![People taking medication](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Prescription%20Drugs.jpg.webp?itok=80c6-VW6)
AMCP opposes legislative proposals that would allow the commercial importation of prescription drugs for sale in the United States
![](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Caragon%20200x200_1.png.webp?itok=4lMCwnv9)
AMCP opposes attempts to erode the Employee Retirement Income Security Act (ERISA) and Medicare Part D preemption. AMCP believes that the certainty that comes with a single uniform federal standard ensures that plans subject to these laws are better able to provide access to needed medications regardless of where the patient lives or works.
Featured Resources
See More Resources![Brief on Prescription Digital Theraputics: Cover Image](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/2024-AMCP-Brief-Operational-Readiness-Covering-Prescription-Digital-Therapeutics-cover.jpg.webp?itok=FSPjYrus)
![AMCP Podcast](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/1024x768_podcast_carousel_1C.jpg.webp?itok=dsmBrRwW)
![AAO Report Presentation - Thumbnail](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Access-Affordability-Outcomes-Value-of-Managed-Care-Pharmacy-AMCP-AAO-presentation-thumb.jpg.webp?itok=p_0pqzoT)
![AMCP Vale-Based Care Lexicon - Presentation Cover](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP_VBC_Advisory-Group_Lexicon_Presentation_cover.jpg.webp?itok=OdDEb100)
![AMCP CEO Susan Cantrell with Members at Legislative Days 2024](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-legislative-hill-days-2024.jpg.webp?itok=bXdOCBIY)
![AMCP 2024 Legislative Days Booklet Cover](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-LEGISLATIVE-DAYS-2024-Booklet-cover.jpg.webp?itok=g8XLv5S-)
Regulatory Updates
Letters, Statements, and Analysis
See All Letters, Statements, & Analysis![Senior or Adult patient looking at ipad - Medicare or Medicaid](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP%20Seniors%20and%20Adults%20Medicare%20-%20ipad.jpg.webp?itok=PCGyb3FL)
View AMCP letter urging Congress to support 12-month continuous eligibility for adults in Medicaid and the Children’s Health Insurance Program (CHIP) by passing the Stabilize Medicaid and CHIP Coverage Act
![Patient in Hospital - Biosimilars 21st Century Cures 2.0 Request for Information](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-biosimilars-patient-stock.jpg.webp?itok=qCO1zJVG)
View AMCP comments to the FDA on considerations in demonstrating biosimilar interchangeability with a biologic reference product.
![A person stating at screens](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Person%20with%20Technology.jpg.webp?itok=BTrLT_Ei)
View AMCP comments in response to the 21st Century Cures 2.0 Request for Information.
Latest NewsBREAKS
Explore Resources by Topic![AMCP Regulatory NewsBreaks](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-Regulatory-NewsBreak-image.jpg.webp?itok=BieTzqCb)
![AMCP Regulatory NewsBreaks](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-Regulatory-NewsBreak-image.jpg.webp?itok=BieTzqCb)
![AMCP Regulatory NewsBreaks](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/AMCP-Regulatory-NewsBreak-image.jpg.webp?itok=BieTzqCb)